PhaseBio Pharmaceuticals Inc
OTC:PHASQ
PhaseBio Pharmaceuticals Inc
OTC:PHASQ
Price:
0.0001
USD
Market Closed
Market Cap:
$49.9
Income Statement
Earnings Waterfall
PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc
Income Statement
PhaseBio Pharmaceuticals Inc
PhaseBio Pharmaceuticals Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|
| Revenue | ||||
| Interest Expense |
1
|
1
|
1
|
|
| Revenue |
2
N/A
|
0
-86%
|
11
+3 285%
|
|
| Operating Income | ||||
| Operating Expenses |
(42)
|
(85)
|
(118)
|
|
| Selling, General & Administrative |
(11)
|
(13)
|
(16)
|
|
| Research & Development |
(31)
|
(72)
|
(102)
|
|
| Operating Income |
(40)
N/A
|
(85)
-114%
|
(107)
-27%
|
|
| Pre-Tax Income | ||||
| Interest Income Expense |
0
|
(14)
|
(22)
|
|
| Total Other Income |
0
|
0
|
0
|
|
| Pre-Tax Income |
(39)
N/A
|
(99)
-151%
|
(129)
-31%
|
|
| Net Income | ||||
| Tax Provision |
0
|
0
|
(2)
|
|
| Income from Continuing Operations |
(39)
|
(99)
|
(131)
|
|
| Net Income (Common) |
(39)
N/A
|
(99)
-151%
|
(131)
-33%
|
|
| EPS (Diluted) |
-1.43
N/A
|
-3.39
-137%
|
-2.98
+12%
|
|
Switch to:
Switch to:
See Also
Discover More
